Development of sarcoidosis following completion of treatment for hepatitis c with pegylated interferon- 2a and ribavirin: A case report and literature review

Clinical Medicine and Research

Volumn 8, Issue 3-4, 2010, Pages 163-167

  Gayet, Albéric Rembrandt ^a   Plaisance, Patrick ^a   Bergmann, Jean François ^a   Mouly, Stéphane ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Chronic hepatitis C; Interferon alpha and ribavirin combination therapy; Sarcoidosis; Spontaneous recovery

Indexed keywords

CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE; PEGINTERFERON ALPHA2A; RIBAVIRIN;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DRUG TOLERABILITY; DYSPNEA; ENZYME BLOOD LEVEL; FATIGUE; FEMALE; HEPATITIS C; HEPATOSPLENOMEGALY; HUMAN; LYMPHOCYTOPENIA; MYALGIA; SARCOIDOSIS; SUBCUTANEOUS NODULE; THORAX PAIN; THORAX RADIOGRAPHY; WEIGHT REDUCTION;

ANTIVIRAL AGENTS; FEMALE; HEPATITIS C; HUMANS; INTERFERON ALFA-2A; MIDDLE AGED; POLYETHYLENE GLYCOLS; REMISSION, SPONTANEOUS; SARCOIDOSIS; TIME FACTORS;

EID: 78650806037     PISSN: 15394182     EISSN: 15546179     Source Type: Journal    
DOI: 10.3121/cmr.2010.886     Document Type: Article

References (44)

1. Costalbel U, Hunninghake GW. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J 1999;14:735-737.
2. Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, Eklund A, Kitaichi M, Lynch J, Rizzato G, Rose C, Selroos O, Semenzato G, Sharma OP. ATS/ERS/ WASOG statement on sarcoidosis. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:149-173.
3. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC Jr, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, et al. Treatment of chronic hepatitis C with recombinant interferon alpha. A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group. N Engl J Med 1989;321:1501-1506.
4. Leclerc S, Myers RP, Moussalli J, Herson S, Poynard T, Benveniste O. Sarcoidosis and interferon therapy: report of five cases and review of the literature. Eur J Intern Med 2003;14:237-243.
5. Ravanel JG, McAdams HP, Plankeel JF, Butnor KJ, Sporn TA. Sarcoidosis induced by interferon therapy. AJR Am J Roentgenol 2001;177:199-201.
6. Ramos-Casals M, Mañà J, Nardi N, Brito-Zeròn P, Xaubet A, Sãnchez-Tapias JM, Cervera R, Font J; HISPAMEC Study Group. Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases. Medicine (Baltimore). 2005;84:69-80.
7. Hoffmann RM, Jung MC, Motz R, Gössi C, Emslander HP, Zachoval R, Pape GR. Sarcoidosis associated with interferonalpha therapy for chronic hepatitis C. J Hepatol 1998;28:1058-1563.
8. Vallina E, Garcìa Dìez A, Gallego M, Villaverde P, Rippe ML, Arribas JM. [A case of pulmonary sarcoidosis induced by interferon alpha treatment in a female patient with hepatitis C.] [Article in Spanish] An Med Interna 2000;17:538-539.
9. Pohl J, Stremmel W, Kallinowski B. [Pulmonal sarcoidosis: A rare side effect of interferon-alpha treatment for chronic hepatitis C infection.] [Article in German]. Z Gastroenterol 2000;38:951-955.
10. Tahan V, Ozseker F, Guneylioglu D, Baran A, Ozaras R, Mert A, Ucisik AC, Cagatay T, Yilmazbayhan D, Senturk H. Sarcoidosis after use of interferon for chronic hepatitis C: report of a case and review of the literature. Dig Dis Sci 2003;48:169-173.
11. Rubinowitz AN, Naidich DP, Alinsonorin C. Interferon-induced sarcoidosis. J Comput Assist Tomogr 2003;27:279-283.
12. Luchi S, Scasso A. Sarcoidosis, chronic hepatitis C and interferon-alpha: two cases. Scand J Infect Dis 2003; 35:775-776.
13. Alazemi S, Campos MA. Interferon-induced sarcoidosis. Int J Clin Pract 2006;60:201-211.
14. Pelletier F, Manzoni P, Jacoulet P, Humbert P, Aubin F. Pulmonary and cutaneous sarcoidosis associated with interferon therapy for melanoma. Cutis 2007;80:441-445.
15. Doycheva D, Deuter C, Stuebiger N, Zierhut M. Interferonalpha- associated presumed ocular sarcoidosis. Graefes Arch Clin Exp Ophtalmol 2009;247:675-680.
16. Butnor KJ. Pulmonary sarcoidosis induced by interferon-alpha therapy. Am J Surg Pathol 2005;29:976-979.
17. Hirano A, Kataoka M, Nakata Y, Takeda K, Kamao T, Hiramatsu J, Kimura G, Tanimoto Y, Kanehiro A, Tanimoto M. Sarcoidosis occurring after interferon-alpha therapy for chronic hepatitis C: report of two cases. Respirology 2005;10:529-534.
18. Celik G, Sen E, Ulger AF, Kumbasar OO, Bozkaya H, Alper D, Karayalcin S. Sarcoidosis caused by interferon therapy. Respirology 2005;10:535-540.
19. Goldberg HJ, Fiedler D, Webb A, Jagirdar J, Hoyumpa AM, Peters J. Sarcoidosis after treatment with interferon-alpha: a case series and review of the literature. Respir Med 2006;100:2063-2068.
20. Pietropaoli A, Modrak J, Utell M. Interferon-alpha therapy associated with the development of sarcoidosis. Chest 1999;116:569-572.
21. Cogrel O, Doutre MS, Marlière V, Beylot-Barry M, Couzigou P, Beylot C. Cutaneous sarcoidosis during interferon alpha and ribavirin treatment of hepatitis C virus infection: two cases. Br J Dermatol 2002;146:320-324.
22. Weyer P, Cummings OW, Knox KS. A 49-year-old woman with hepatitis, confusion, and abnormal chest radiograph findings. Chest 2005;128:3076-3079.
23. Savoye G, Goria O, Herve S, Riachi G, Noblesse I, Bastien L, Courville P, Lerebours E. Probable cutaneous sarcoidosis associated with combined ribavirin and interferon-alpha therapy for chronic hepatitis C.] [Article in French]. Gastroenterol Clin Biol 2000;24:679.
24. Lévêque L, de Boulard A, Bielefeld P, Sgro C, Hillon P, Gabreau T, Champigneulle B, Makki H, Besancenot JF. [Sarcoidosis during the treatment of hepatitis C by interferonalpha and ribavirin: 2 cases.] [Article in French]. Rev Med Interne 2001;22:1248-1252.
25. Pérez-Alvarez R, Pérez-Lòpez R, Lombraña JL, Rodrìguez M, Rodrigo L. Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine. J Viral Hepat 2002;9:75-79.
26. Wendling J, Descamps V, Grossin M, Marcellin P, Le Bozec P, Belaich S, Crickx B. Sarcoidosis during combined interferon alpha and ribavirin therapy in 2 patients with chronic hepatitis C. Arch Dermatol 2002;138:546-547.
27. Gitlin N. Manifestation of sarcoidosis during interferon and ribavirin therapy for chronic hepatitis C: a report of two cases. Eur J Gastroenterol Hepatol 2002;14:883-885.
28. Alfageme Michavila I, Merino Sànchez M, Pérez Ronchel J, Lara Lara I, Suàrez Garcìa E, Lòpez Garrido J. [Sarcoidosis following combined ribavirin and interferon therapy: a case report and review of the literature.] [Article in Spanish] Arch Bronconeumol 2004;40:45-49.
29. Yan KK, Dinihan I, Freiman J, Zekry A. Sarcoidosis presenting with granulomatous uveitis induced by pegylated interferon and ribavirin therapy for Hepatitis C. Intern Med J 2008;38:207-210.
30. Bolukbas C, Bolukbas FF, Kebdir T, Canayaz L, Dalay AR, Kilic G, Ovunc O. Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C--a case report and review of the literature. Acta Gastroenterol Belg 2005;68:432-434.
31. Hurst EA, Mauro T. Sarcoidosis associated with pegylated interferon alpha and ribavirin treatment for chronic hepatitis C: a case report and review of the literature. Arch Dermatol 2005;141:865-868.
32. Seaton A, Seaton D, Leitch AG. Sarcoidosis. In: Crofton and Douglas's Respiratory Disease. 4th ed. Oxford, UK: Wiley- Blackwell;1989. 630.
33. Gerke AK, Hunninghake G. The immunology of sarcoidosis. Clin Chest Med 2008;29:379-390.
34. Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet 2003;362:2095-2100.
35. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL, Häussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J. Peginteferon alpha-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002;347:975-982.
36. Schattner A. Interferons and autoimmunity. Am J Med Sci 1988;295;532-544.
37. Shiomi S, Kuroki T, Yokogawa T, Takeda T, Nishiguchi S, Nakajima S, Tanaka T, Okamura T, Ochi H. Changes in results of Gallium-67-citrate scanning after interferon therapy for chronic hepatitis C. J Nucl Med 1997;38:216-219.
38. Ning Q, Brown D, Parodo J, Cattral M, Gorczynski R, Cole E, Fung L, Ding JW, Liu MF, Rotstein O, Phillips MJ, Levy G. Rivabirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgI2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol 1998;160:3487-3493.
39. Tam RC, Pai B, Bard J, Lim C, Averett DR, Phan UT, Milovanovic T. Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile. J Hepatol 1999; 30:376-382.
40. Blum L, Serfaty L, Wattiaux MJ, Picard O, Cabane J, Imbert JC. [Nodules hypodermiques sarcoidosiques au cours d'une hépatite virale C traitée par interféron alpha 2b] [Article in French]. Rev Med Interne 1993;14:1161.
41. Nunes H, Soler P, Valeyre D. Pulmonary sarcoidosis. Allergy 2005;60:565-582.
42. Paramothayan S, Jones PW. Corticosteroid therapy in pulmonary sarcoidosis: a systematic review. JAMA 2002;287:1301-1307.
43. Thomas KW, Hunninghake GW. Sarcoidosis. JAMA 2003;289:3300-3003.
44. Baudin B. [Angiotensin I- converting enzyme (ACE) for sarcoidosis diagnosis.] [Article in French]. Pathol Biol (Paris) 2005;53:183-188.